The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia
New treatments are urgently needed for serious mental illnesses including bipolar disorder and schizophrenia. This review proposes that Garcinia mangostana Linn. (mangosteen) pericarp is a possible adjunctive therapeutic agent for these disorders. Research to date demonstrates that neurobiological p...
Main Authors: | Melanie M. Ashton, Olivia M. Dean, Adam J. Walker, Chiara C. Bortolasci, Chee H. Ng, Malcolm Hopwood, Brian H. Harvey, Marisa Möller, John J. McGrath, Wolfgang Marx, Alyna Turner, Seetal Dodd, James G. Scott, Jon-Paul Khoo, Ken Walder, Jerome Sarris, Michael Berk |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpsyt.2019.00115/full |
Similar Items
-
The Effect of Adjunctive Mangosteen Pericarp on Cognition in People With Schizophrenia: Secondary Analysis of a Randomized Controlled Trial
by: Wolfgang Marx, et al.
Published: (2021-06-01) -
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
by: Lauren Arancini, et al.
Published: (2019-09-01) -
Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
by: Rickinder Sethi, et al.
Published: (2019-09-01) -
Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression
by: Olivia M. Dean, et al.
Published: (2015-03-01) -
Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0
by: Estela Salagre, et al.
Published: (2018-11-01)